Soleno Therapeutics, Inc. (SLNO)
NASDAQ: SLNO · Real-Time Price · USD
38.57
+0.44 (1.15%)
At close: Mar 5, 2026, 4:00 PM EST
38.40
-0.17 (-0.44%)
After-hours: Mar 5, 2026, 4:09 PM EST
Soleno Therapeutics Stock Forecast
Stock Price Forecast
The 11 analysts with 12-month price forecasts for Soleno Therapeutics stock have an average target of 108, with a low estimate of 75 and a high estimate of 145. The average target predicts an increase of 180.01% from the current stock price of 38.57.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Soleno Therapeutics stock from 11 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 4 | 4 | 4 | 5 | 5 |
| Buy | 5 | 6 | 6 | 6 | 6 | 6 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 10 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $120 → $100 | Strong Buy | Maintains | $120 → $100 | +159.27% | Mar 4, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $114 → $110 | Buy | Maintains | $114 → $110 | +185.20% | Feb 27, 2026 |
| TD Cowen | TD Cowen | Strong Buy Maintains $120 → $85 | Strong Buy | Maintains | $120 → $85 | +120.38% | Feb 26, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $106 → $114 | Buy | Maintains | $106 → $114 | +195.57% | Jan 20, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $110 → $120 | Strong Buy | Maintains | $110 → $120 | +211.12% | Jan 20, 2026 |
Financial Forecast
Revenue This Year
486.37M
from 190.41M
Increased by 155.44%
Revenue Next Year
768.40M
from 486.37M
Increased by 57.99%
EPS This Year
4.30
from 0.39
Increased by 1,001.68%
EPS Next Year
6.95
from 4.30
Increased by 61.79%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 591.2M | 924.0M | |
| Avg | 486.4M | 768.4M | |
| Low | 425.0M | 628.2M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 210.5% | 90.0% | |
| Avg | 155.4% | 58.0% | |
| Low | 123.2% | 29.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 5.83 | 10.42 | |
| Avg | 4.30 | 6.95 | |
| Low | 2.85 | 5.21 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1,394.2% | 142.4% | |
| Avg | 1,001.7% | 61.8% | |
| Low | 631.2% | 21.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.